VR Logo

Sequent Scientific Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1985

Chairman: Gopakumar G Nair

Managing Director: Manish Gupta

Group: Sequent

Listing: NSE: SEQUENT, BSE: 512529

Headquarters: Thane, Maharashtra

Website: http://www.sequent.in/

Key Facts

Market cap: R 3,833.61 Cr

Revenue (TTM): R 1,211.49 Cr

Earnings (TTM): R 91.22 Cr

Cash: R 116.00 Cr

Total Debt: R 330.65 Cr

Promoters' ownership: 54.51%

Liquidity: High

52 Week range: R 51.70 - 168.80

Face value: R2.00

Shares outstanding: 24,83,70,995

10 Years Aggregate:

  • CFO: 268.31 Cr
  • EBITDA: 608.20 Cr
  • Net Profit: 344.55 Cr

Stock Performance

Time Period Sequent Scientific S&P BSE Healthcare S&P BSE Small Cap
YTD118.7846.2310.48
1 month2.691.334.38
3 months35.2814.3916.45
1 Year108.7252.6914.46
3 Years11.0911.80-3.98
5 Years-3.601.475.60
10 Years20.1011.713.50
As on 23-Oct-2020
Year Sequent Scientific S&P BSE Small Cap S&P BSE Healthcare
20194.13-6.85-3.55
2018-30.98-23.41-5.89
2017-10.9959.640.49
2016-55.481.77-12.88
2015144.446.7615.06
2014156.0369.2447.43
2013-10.09-11.2322.55